Compared with succinate-treated p53+/+ mice, the hyperplasia of tuft and goblet cells and the increase of ILC2 numbers and eosinophilia were much less pronounced in succinate-treated p53−/− mice (Fig. 2a, b, Fig. S2a, b). The gene discussed is TP53; the disease is Increased total eosinophil count.